Trial intelligence / Profile preview

Topical Herbal Solution vs Minoxidil 5% for Androgenetic Alopecia

NCT03753113Phase 3Completed

Start
Nov 2018
Primary completion
Sep 2019
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in androgenetic alopecia (AGA) (2 arms). Primary endpoint: Change in Hair Diameter at 36 weeks. Started Nov 2018; status: completed.

02

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT03753113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03753113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call